The producer of sustainable biopesticides said the new facility will allow it to do more in-house, including formulation, microbiological screening, plant and seed evaluations and analytical work. It also features high-tech plant growth chambers, to undertake relatively rapid, small scale tests on different plant species.
Eden said it plans to use the laboratory for insect-focused work to develop its first bioinsecticide products, so it can enter new addressable markets worth €850mln in the EU and US combined.
Milton Park is home to more than 250 companies and over 9,000 workers and is one of the largest science clusters in the country, the AIM-listed firm said, and the innovative business community is “a perfect fit” to relocate as part of its strategic ambition to capitalise on new product and market opportunities.
“The opening of our new laboratory facilities is an important milestone for Eden,” chief executive Sean Smith said in a statement.
“The fact that we now have the ability to conduct in-house research and development improves the efficiency of our operations, helping us to expand the footprint of our business through product development.”
"Milton Park is well regarded for being home to some of the UK's top science and technology firms. We are excited to be joining the community and look forward to continuing our work in sustainable agriculture from our new Oxfordshire base," he added.
Shares rose 1% to 8.39p early on Wednesday.